Source:http://linkedlifedata.com/resource/pubmed/id/10759725
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-6-2
|
pubmed:abstractText |
We have recently reported the possibility of supporting the phase of severe thrombocytopenia after high-dose chemotherapy (HDC) and stem cell transplantation using 5% dimethylsulphoxide (DMSO)-cryopreserved autologous platelet concentrates (PCs). The aim of the present study was to evaluate the therapeutic potential of ThromboSol (a recently developed platelet storage solution) plus PCs cryopreserved in 2% DMSO in patients undergoing myeloablative chemotherapy and autologous transplantation. PCs were collected from 14 women with breast cancer by a single plateletapheresis and cryopreserved in ThromboSol/2% DMSO by either direct insertion in a -80 degrees C freezer or in liquid nitrogen after computer-controlled rate (CR) freezing. When required, PCs were thawed, centrifuged to remove the cryoprotectants and transfused. In vitro studies on thawed platelets showed loss of epitopes of surface glycoproteins and a marked reduction of functional activity compared with fresh platelets. Transfusion of CR-frozen PCs was associated with a mean 1 h corrected count increment (CCI) of 9.2 +/- 5.4 x 109/l and only one allogeneic PC was required in this group. In contrast, six out of seven patients required additional allogeneic transfusions in the -80 degrees C group (CCI = 2.7 +/- 1.4 x 109/l). ThromboSol-treated PCs have the ability to overcome thrombocytopenia if processed by a CR freezing protocol, but appear ineffective when frozen by direct placing at -80 degrees C.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
653-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10759725-Blood Transfusion, Autologous,
pubmed-meshheading:10759725-Breast Neoplasms,
pubmed-meshheading:10759725-Cryopreservation,
pubmed-meshheading:10759725-Cryoprotective Agents,
pubmed-meshheading:10759725-Dimethyl Sulfoxide,
pubmed-meshheading:10759725-Drug Administration Schedule,
pubmed-meshheading:10759725-Female,
pubmed-meshheading:10759725-Flow Cytometry,
pubmed-meshheading:10759725-Humans,
pubmed-meshheading:10759725-Pilot Projects,
pubmed-meshheading:10759725-Platelet Aggregation,
pubmed-meshheading:10759725-Platelet Transfusion,
pubmed-meshheading:10759725-Thrombocytopenia
|
pubmed:year |
2000
|
pubmed:articleTitle |
Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study.
|
pubmed:affiliation |
Divisione di Oncologia Medica, IRCCS Fondazione 'S. Maugeri', Pavia, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|